ArticleJournal of robotic surgery2026
Single-port EDGE SP1000 versus multi-port Da Vinci Xi robot-assisted radical prostatectomy: a comparative analysis of technique and perioperative outcomes.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The EDGE single-port endoscopic surgical robot (SP1000), specifically designed for urological, gynecological, thoracic and general surgical procedures, has recently been applied in various operations. However, there is currently a lack of evidence comparing its performance with the Da Vinci Xi robot system. This study aims to compare the technique and perioperative outcomes of radical prostatectomy (RP) performed with EDGE SP1000 versus the Da Vinci Xi robot system. Data were collected from radical prostatectomy cases performed at Anhui Medical University from March 2025 to December 2025. 101 patients underwent radical prostatectomy using EDGE SP1000 and 102 patients using Da Vinci Xi were operated on using the Da Vinci Xi system. A 1:1 propensity score matching method was applied to compare the two groups both before and after matching based on age, body mass index, prostate size, prostate specific antigen (PSA) level, and Gleason score. We primarily evaluated the surgical efficacy of the two robotic systems by comparing perioperative clinical data. In the matched surgery groups (EDGE SP1000 vs. Da Vinci Xi), there were no significant differences in age (68.6 years vs. 69.3 years; p = 0.59), PSA (10.3 ng/ml vs. 10.1 ng/ml; p = 0.93), Gleason score (7 vs. 7; p = 0.41) and prostate volume (38.0 cm
Indexed as
Identifiers
42133277What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.